Definitive Healthcare (DH) vs Expensify (EXFY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Expensify (EXFY) has outperformed Definitive Healthcare (DH) over the past year, gaining 0.0% versus a loss of 56.5%. Over five years, DH leads with a -96.0% price change compared with -97.0% for EXFY. Expensify is the larger company by market cap ($134.0 million vs $128.6 million), about 1.0 times the size.
On valuation, Definitive Healthcare trades at a lower forward P/E (6.5x vs 15.5x for Expensify). Expensify converts more of its revenue into profit, with a net margin of -15.1% versus -57.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DH | EXFY |
|---|---|---|
| Share price | $1.20 | $1.45 |
| Market cap | $128.60M | $133.97M |
| 1-day change | -0.83% | -7.64% |
| YTD return | -58.19% | -3.97% |
| 1-year return | -56.52% | 0.00% |
| 5-year return | -95.99% | -97.01% |
| Forward P/E | 6.45 | 15.54 |
| EPS (TTM) | $-1.50 | $-0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $241.52M | $142.10M |
| Revenue growth (YoY) | -4.24% | +2.06% |
| Net income (latest FY) | $-138.93M | $-21.39M |
| Gross margin | 75.88% | 50.34% |
| Operating margin | -92.86% | -12.68% |
| Net margin | -57.52% | -15.05% |
| 52-week high | $3.00 | $2.81 |
| 52-week low | $0.61 | $0.691 |
| Distance from 52-week high | -60.00% | -48.40% |
| Analyst consensus | hold | hold |
| Avg. price target upside | +35.83% | +95.17% |
| Average volume | 682.42K | 542.50K |
| Shares outstanding | 107.16M | 80.05M |
| Employees | 678 | 117 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EXFY has outperformed DH by 56.5 percentage points over the past year.
- Expensify is more profitable, keeping -15.1 cents of every revenue dollar as net income versus -57.5 cents for Definitive Healthcare.
- Expensify grew revenue faster in its latest fiscal year (+2.06% vs -4.24%).
About Definitive Healthcare
DH stock →Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Technology · Computer Software: Prepackaged Software · 678 employees
About Expensify
EXFY stock →Expensify, Inc. provides a cloud-based expense management software platform in the United States and internationally.
Technology · Computer Software: Prepackaged Software · 117 employees
DH vs EXFY FAQ
Which is bigger, Definitive Healthcare or Expensify?
Expensify (EXFY) is larger, with a market capitalization of $133.97M compared with $128.60M for Definitive Healthcare (DH).
Which stock has performed better over the past year, DH or EXFY?
EXFY returned 0.00% over the past 12 months, compared with -56.52% for DH (price return, excluding dividends). Past performance does not predict future results.
Are Definitive Healthcare and Expensify in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.